back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-28 10:46 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+43,333 vol |
360,333 | |
| Filed 2024-03-28 10:45 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+117,000 vol |
317,000 | |
| Filed 2024-03-28 10:45 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,333 vol |
133,334 | |
| Filed 2024-03-28 10:44 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-63,000 vol |
156,667 | |
| Filed 2024-03-28 10:44 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-43,333 vol |
219,667 | |
| Filed 2024-03-28 10:44 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-117,000 vol |
263,000 | |
| Filed 2024-03-18 11:50 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+180,000 vol |
380,000 | |
| Filed 2024-03-18 11:49 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2024-03-18 11:48 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-12 14:54 Tx date 2023-09-11 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-100,000 vol |
200,000 | |
| Filed 2023-08-15 14:50 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
1,025,000 | |
| Filed 2023-04-16 00:13 Tx date 2023-04-13 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-100,000 vol |
300,000 | |
| Filed 2021-12-06 15:55 Tx date 2021-12-06 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-100,000 vol |
400,000 | |
| Filed 2021-09-05 20:46 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$236,000
+400,000 vol $0.59 each |
800,000 | |
| Filed 2021-09-05 20:34 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$147,500
+250,000 vol $0.59 each |
||
| Filed 2020-06-17 08:44 Tx date 2020-06-11 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
400,000 | |
| Filed 2019-09-22 17:19 Tx date 2019-09-13 |
$
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2019-09-22 17:19 Tx date 2019-09-13 |
$
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 |